Psychemedics Corporation

Company Profile

Psychemedics Corporation had its IPO on 1994-02-17 under the ticker symbol PMD.

The company operates in the LIFE SCIENCES sector and SERVICES-MEDICAL LABORATORIES industry. Psychemedics Corporation has a staff strength of 0 employees.

Stock update

Shares of Psychemedics Corporation opened at $6.45 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $6.45 - $6.45, and closed at $6.45.

This is a -1.6% slip from the previous day's closing price.

A total volume of 366 shares were traded at the close of the day’s session.

In the last one week, shares of Psychemedics Corporation have increased by +7.5%.

Psychemedics Corporation's Key Ratios

Psychemedics Corporation has a market cap of $0.036 billion, indicating a price to book ratio of 3.031 and a price to sales ratio of 1.389.

In the last 12-months Psychemedics Corporation’s revenue was $0.026 billion with a gross profit of $0.010 billion and an EBITDA of $0.002 billion. The EBITDA ratio measures Psychemedics Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Psychemedics Corporation’s operating margin was -1.79% while its return on assets stood at -1.3% with a return of equity of -9.43%.

In Q2, Psychemedics Corporation’s quarterly earnings growth was a negative -30.2% while revenue growth was a positive 7%.

Psychemedics Corporation’s PE and PEG Ratio

Forward PE

-

Trailing PE

-

PEG

0

Its diluted EPS in the last 12-months stands at $-0.127 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Psychemedics Corporation’s profitability.

Psychemedics Corporation stock is trading at a EV to sales ratio of 1.482 and a EV to EBITDA ratio of 12.39. Its price to sales ratio in the trailing 12-months stood at 1.389.

Psychemedics Corporation stock pays annual dividends of $0.19 per share, indicating a yield of 4.33% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Psychemedics Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Psychemedics Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Psychemedics Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Psychemedics Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Psychemedics Corporation paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$6.45

52-Week High

$8.65

52-Week Low

$5.88

Analyst Target Price

$32

Psychemedics Corporation stock is currently trading at $6.45 per share. It touched a 52-week high of $8.65 and a 52-week low of $8.65. Analysts tracking the stock have a 12-month average target price of $32.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.